PhenoID, a language model normalizer of physical examinations from genetics clinical notes - Weissenbacher, Davy; Rawal, Siddharth; Zhao, Xinwei; Priestley, Jessica R. C.; Szigety, Katherine M.; Schmidt, Sarah F.; Higgins, Mary J.; Magge, Arjun; O’Connor, Karen; Gonzalez-Hernandez, Graciela; Campbell, Ian M. (medRxiv, 2024)
Background Phenotypes identified during dysmorphology physical examinations are critical to genetic diagnosis and nearly universally documented as free-text in the electronic health record (EHR). Variation in how phenotypes are recorded in free-text makes large-scale computational analysis extremely challenging. Existing natural language processing (NLP) approaches to address phenotype extraction are trained largely on the biomedical literature or on case vignettes rather than actual EHR data.Methods We implemented a tailored system at the Children’s Hospital of Philadelpia that allows clinicians to document dysmorphology physical exam findings. From the underlying data, we manually annotated a corpus of 3136 organ system observations using the Human Phenotype Ontology (HPO). We provide this corpus publicly. We trained a transformer based NLP system to identify HPO terms from exam observations. The pipeline includes an extractor, which identifies tokens in the sentence expected to contain an HPO term, and a normalizer, which uses those tokens together with the original observation to determine the specific term mentioned.Findings We find that our labeler and normalizer NLP pipeline, which we call PhenoID, achieves state-of-the-art performance for the dysmorphology physical exam phenotype extraction task. PhenoID’s performance on the test set was 0.717, compared to the nearest baseline system (Pheno-Tagger) performance of 0.633. An analysis of our system’s normalization errors shows possible imperfections in the HPO terminology itself but also reveals a lack of semantic understanding by our transformer models.Interpretation Transformers-based NLP models are a promising approach to genetic phenotype extraction and, with recent development of larger pre-trained causal language models, may improve semantic understanding in the future. We believe our results also have direct applicability to more general extraction of medical signs and symptoms.Funding US National Institutes of HealthCompeting Interest StatementGraciela Gonzalez-Hernandez is a consultant to F. Hoffmann-La Roche Ltd (Roche Pharmaceuticals).Funding StatementThis study was funded by the grant K08-HD111688 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board at Children’s Hospital of Philadelphia determined that this study met exemption criteria under 45 CFR 46.104(d)4(iii) as protocol 22-019752. A waiver of HIPAA authorization under 45 CFR 164.512(i)(2)(ii) was granted to access identifiable information from the medical records. This study uses manually de-identified data. Newly annotated training data is available at https://github.com/Ian-Campbell-Lab/Clinical-Genetics-Training-Data/. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://github.com/Ian-Campbell-Lab/Clinical-Genetics-Training-Data/